3-(1H-2-INDOLYL)-4-(4-METHOXYPHENYL)-1-METHYL-1H-2-QUINOLINONE, 97.0%, 250mg

(R)-3-Cyclohexyl-2-hydroxypropanoic acid, 95%, 1g

(R)-S-tert-Butyl 2-methylpropane-2-sulfinothioate, 95.0%, 1g

(2,5-Dimethyl-benzenesulfonylamino)-acetic acid, 95.0%, 100mg

2-(3-BROMOPROPYL)-1,2-OXAZINANE, 95.0%, 500mg

3-(3-Methoxyphenyl)-3-oxopropanenitrile, 95.0%, 10g

Hybridisation vial Non-coated, Height, 150 mm, 35 mm, 1 Piece

N-(2-Aminoethyl)methanesulfonamide hydrochloride, 97%, 1g

(4-Fluorophenyl)methanamine hydrochloride, 97%, 5g

4,4'-(Ethane-1,2-diyl)bis(morpholine-2,6-dione), 95.0%, 25g

(6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methanamine hydrochloride, 97%, 100mg

5-Bromo-4-methylthiophene-2-carbonitrile, 95+%, 250mg

N,N'-Di([1,1'-biphenyl]-2-yl)ethanediamide>98.0%(HPLC)1g